बुडेसोनाइड और फॉर्मोटेरोल और मेथएम्फेटामाइन का इंटरैक्शन

Clinically significant cardiovascular effects and fatalities have been reported in association with excessive use of inhaled sympathomimetic drugs.

Fatalities have been reported in association with excessive use of inhaled sympathomimetic drugs.

Serious asthma-related events: Long-acting beta2-adrenergic agonists as monotherapy increase the risk.

Therefore, budesonide and formoterol fumarate dihydrate, like all products containing sympathomimetic amines, should be used with caution in patients with cardiovascular disorders, especially coronary insufficiency, cardiac arrhythmias, and hypertension.

Coexisting Conditions Budesonide and formoterol fumarate dihydrate, like all medications containing sympathomimetic amines, should be used with caution in patients with convulsive disorders or thyrotoxicosis and in those who are unusually responsive to sympathomimetic amines.

Tricyclic Antidepressants Clinical Impact: May enhance the activity of tricyclic or sympathomimetic agents causing sustained increases in the concentration of d-amphetamine in the brain; cardiovascular effects can be potentiated.

Drug/Laboratory Test Interactions Amphetamines can cause a significant elevation in plasma corticosteroid levels.

Amphetamines may interfere with urinary steroid determinations.